Skip to content
Research/Peptide Blends Stacks/Tesamorelin + Ipamorelin + MOTS-c

Tesamorelin + Ipamorelin + MOTS-c

Advanced metabolic + longevity stack combining visceral fat reduction (Tesamorelin), GH release (Ipamorelin), and mitochondrial optimization (MOTS-c). Visceral fat loss, GH optimization, metabolic health, longevity.

Intelligence Profile

Science

Mechanism of Action

Based on limited available evidence, this combination therapy consists of three distinct peptides, each with different mechanisms of action:

Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates the anterior pituitary gland to increase endogenous growth hormone (GH) production. Growth hormone subsequently promotes the release of insulin-like growth factor-1 (IGF-1) from the liver, which mediates many of the anabolic effects including protein synthesis and tissue repair.

Ipamorelin functions as a growth hormone secretagogue receptor (GHSR) agonist, specifically targeting the ghrelin receptor. This mechanism also results in increased GH release from the pituitary, but through a different pathway than GHRH analogs. Ipamorelin is designed to be more selective than other growth hormone secretagogues, potentially reducing unwanted effects on cortisol and prolactin levels.

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA-c) is a mitochondrial-derived peptide that appears to regulate cellular metabolism. Current research suggests it may influence glucose metabolism, mitochondrial function, and cellular energy production, though the exact mechanisms are still being investigated.

Evidence Limitations: The available evidence for this specific combination is extremely limited. Only one review article from 2026 discussing peptide therapies for musculoskeletal applications was identified, and no clinical trials specifically examining this three-peptide combination were found. The individual mechanisms described above are based on general knowledge of these peptides' known pathways, but evidence supporting their combined use or synergistic effects is not available in the current literature.

This information is for educational purposes only and should not be considered medical advice. Consult healthcare professionals for guidance on peptide therapies.